EVITATEST THE RISK-FREE CHROMOSOME ANALYSIS Trademark

Trademark Overview


On Tuesday, June 15, 2021, a trademark application was filed for EVITATEST THE RISK-FREE CHROMOSOME ANALYSIS with the United States Patent and Trademark Office. The USPTO has given the EVITATEST THE RISK-FREE CHROMOSOME ANALYSIS trademark a serial number of 90773761. The federal status of this trademark filing is REGISTERED as of Tuesday, November 1, 2022. This trademark is owned by ARCEDI BIOTECH ApS. The EVITATEST THE RISK-FREE CHROMOSOME ANALYSIS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services, namely, medical diagnosis and treatment of prenatal disorders; Medical services, namely, medical testing for diagnostic or treatment purposes for prenatal disorders; Medical services, namely, cell-based non-invasive medical diagnosis of prenatal disorders; Performing non-invasive medical diagnosis of prenatal disorders; Medical services relating to the isolation of human fetal cells from maternal human blood, namely, performing medical testing on human fetal cells separated from maternal blood for diagnosing and treating prenatal disorders, medical diagnosis of prenatal disorders via analysis of samples of human fetal cells isolated from maternal human blood; Medical services, namely, performing genetic testing on human fetal cells isolated from maternal human blood for medical purposes
evitatest the risk-free chromosome analysis

General Information


Serial Number90773761
Word MarkEVITATEST THE RISK-FREE CHROMOSOME ANALYSIS
Filing DateTuesday, June 15, 2021
Status700 - REGISTERED
Status DateTuesday, November 1, 2022
Registration Number6887553
Registration DateTuesday, November 1, 2022
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "EVITATEST" in blue with the words "THE RISK-FREE CHROMOSOME ANALYSIS" in blue to the right of "EVITATEST".
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Translation of Words in MarkThe wording "EVITA" has no meaning in a foreign language.
Goods and ServicesMedical services, namely, medical diagnosis and treatment of prenatal disorders; Medical services, namely, medical testing for diagnostic or treatment purposes for prenatal disorders; Medical services, namely, cell-based non-invasive medical diagnosis of prenatal disorders; Performing non-invasive medical diagnosis of prenatal disorders; Medical services relating to the isolation of human fetal cells from maternal human blood, namely, performing medical testing on human fetal cells separated from maternal blood for diagnosing and treating prenatal disorders, medical diagnosis of prenatal disorders via analysis of samples of human fetal cells isolated from maternal human blood; Medical services, namely, performing genetic testing on human fetal cells isolated from maternal human blood for medical purposes
Disclaimer with Predetermined Text"THE RISK-FREE CHROMOSOME ANALYSIS"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 1, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameARCEDI BIOTECH ApS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressVejle DK-7100
DK

Party NameARCEDI BIOTECH ApS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressVejle DK-7100
DK

Party NameARCEDI BIOTECH ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressVejle DK-7100
DK

Trademark Events


Event DateEvent Description
Friday, February 16, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 1, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 1, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, September 9, 2022NOTICE OF ALLOWANCE CANCELLED
Tuesday, September 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 9, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 8, 2022ASSIGNED TO EXAMINER
Wednesday, March 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 15, 2022ASSIGNED TO LIE
Monday, March 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 15, 2021NON-FINAL ACTION E-MAILED
Wednesday, December 15, 2021NON-FINAL ACTION WRITTEN
Tuesday, December 7, 2021ASSIGNED TO EXAMINER
Wednesday, September 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 18, 2021NEW APPLICATION ENTERED